Fig. 4

Estimated OS (a) and TFS (b) for thalassemia patients receiving MSD and UD-HSCT based on the novel conditioning regimen (MSD: UD = 28:60). Taking into account the degree of allelic HLA matching, the OS (c) and TFS (d) were further compared between MSD, MUD and MMUD (MSD: MUD: MMUD = 28:32:28)